Literature DB >> 20199539

H syndrome: novel and recurrent mutations in SLC29A3.

T P Priya1, N Philip, V Molho-Pessach, T Busa, A Dalal, A Zlotogorski.   

Abstract

The H syndrome (OMIM 612391) is a recently described autosomal recessive disorder characterized by cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, short stature (low height), hyperglycaemia/diabetes mellitus, hallux valgus, and fixed flexion contractures of the toe and finger joints.(1,2) Histologically, there is an inflammatory infiltrate consisting mainly of histiocytes, later replaced by fibrosis of the deep dermis and subcutis.(3) In total, 31 patients have been reported in the literature with the clinical phenotype characteristic of this syndrome.(1-7)

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199539     DOI: 10.1111/j.1365-2133.2010.09653.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

1.  A Case of SLC29A3 Spectrum Disorder-Unresponsive to Multiple Immunomodulatory Therapies.

Authors:  Anoop Mistry; David Parry; Bipin Matthews; Philip Laws; Mark Goodfield; Sinisa Savic
Journal:  J Clin Immunol       Date:  2016-05-23       Impact factor: 8.317

2.  Accelerated coronary atherosclerosis and H syndrome.

Authors:  Ravindranath K Shankarappa; Rajiv Ananthakrishna; Ravi S Math; Sachin Dhareppa Yalagudri; Satish Karur; Ramesh Dwarakaprasad; Manjunath C Nanjappa; Vered Molho-Pessach
Journal:  BMJ Case Rep       Date:  2011-10-04

3.  Unusual facial lesions in H syndrome.

Authors:  Mariem Rekik; Emna Bahloul; Mohamed Ben Rejeb; Khadija Sellami; Slim Charfi; Hamza Chouk; Tahya Boudaouara; Hamida Turki
Journal:  Clin Case Rep       Date:  2022-07-18

4.  Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.

Authors:  Md Fazlur Rahman; Candice Askwith; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

5.  A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.

Authors:  Alexandre Bolze; Avinash Abhyankar; Audrey V Grant; Bhavi Patel; Ruchi Yadav; Minji Byun; Daniel Caillez; Jean-Francois Emile; Marçal Pastor-Anglada; Laurent Abel; Anne Puel; Rajgopal Govindarajan; Loic de Pontual; Jean-Laurent Casanova
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

Review 6.  Regulatory strategies limiting endosomal Toll-like receptor activation in B cells.

Authors:  Mridu Acharya; Shaun W Jackson
Journal:  Immunol Rev       Date:  2022-01-17       Impact factor: 10.983

7.  The histopathology and phenotypic variability in H syndrome.

Authors:  David Dias-Polak; Margarita Indelman; Reuven Bergman; Emily Avitan-Hersh
Journal:  Clin Case Rep       Date:  2018-01-25

8.  Adult stem cell deficits drive Slc29a3 disorders in mice.

Authors:  Sreenath Nair; Anne M Strohecker; Avinash K Persaud; Bhawana Bissa; Shanmugam Muruganandan; Craig McElroy; Rakesh Pathak; Michelle Williams; Radhika Raj; Amal Kaddoumi; Alex Sparreboom; Aaron M Beedle; Rajgopal Govindarajan
Journal:  Nat Commun       Date:  2019-07-03       Impact factor: 14.919

9.  The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis.

Authors:  Mahmoud Mikdar; Pedro González-Menéndez; Xiaoli Cai; Yujin Zhang; Marion Serra; Abdoul K Dembele; Anne-Claire Boschat; Sylvia Sanquer; Cerina Chhuon; Ida Chiara Guerrera; Marc Sitbon; Olivier Hermine; Yves Colin; Caroline Le Van Kim; Sandrina Kinet; Narla Mohandas; Yang Xia; Thierry Peyrard; Naomi Taylor; Slim Azouzi
Journal:  Blood       Date:  2021-06-24       Impact factor: 25.476

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.